{
    "clinical_study": {
        "@rank": "156324", 
        "acronym": "LAMVIRE", 
        "arm_group": {
            "arm_group_label": "patient with Acute Myelo\u00efd Leukemia", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "Infectious morbidity and mortality is a major complication of AML (Acute Myeloid Leukemia)\n      induction and consolidation chemotherapies related aplasia. The main aim of this study is to\n      measure incidence of respiratory viral infections during AML induction and consolidation\n      chemotherapy related aplasia. Primary end point is a positive polymerase chain\n      reaction(PCR)associated with clinical signs."
        }, 
        "brief_title": "Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Myeloid Leukemia", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Myeloid, Acute", 
                "Leukemia, Myeloid", 
                "Virus Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "Bacterial and fungal infection treatment is well defined with guidelines. Few data are\n      available for viral infections and concern essentially allogeneic stem cell transplantation.\n      These infections are associated with a high mortality and morbidity rate. Data concerning\n      AML are essentially retrospective, pediatric and with a little number of patients.\n      Respiratory viral infections incidence is not known. These infections may be responsible for\n      a higher mortality rate. Different risk factors are found: age superior to 65 years,\n      lymphopenia, co-infections. Treatment is subject to a controversy: surveillance or starting\n      an antiviral therapy. This study aims at understanding viral infections epidemiology during\n      long term aplasia and optimizing their management."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients over 18 years old with an AML diagnostic and treated with induction and\n             consolidation chemotherapy. Patients enrolled in another protocol may be included.\n\n          -  Patients with relapsed leukemia who are treated with a salvage intensive therapy stay\n             in the study\n\n          -  Patients who have signed a consent policyholder\n\n        Exclusion Criteria:\n\n          -  patients under 18 years old\n\n          -  patients treated with another treatment than induction and consolidation chemotherapy\n\n          -  pregnant women\n\n          -  patients HIV, HBV or HBC positive\n\n          -  patients with a positive PCR at J1\n\n          -  patients treated with an antiviral treatment or an immunosuppressive treatment for\n             another pathology\n\n          -  patients under guardianship\n\n          -  Primitive immunity Deficit"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "115", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01819792", 
            "org_study_id": "PI2011-843-0005"
        }, 
        "intervention": {
            "arm_group_label": "patient with Acute Myelo\u00efd Leukemia", 
            "intervention_name": "Multiplex respiratory viral PCR", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Acute Myeloid Leukemia", 
        "lastchanged_date": "February 4, 2014", 
        "location": [
            {
                "contact": {
                    "email": "marolleau.jean-pierre@chu-amiens.fr", 
                    "last_name": "JEAN PIERRE MAROLLEAU, MD PhD", 
                    "phone": "03-22-45-59-14"
                }, 
                "facility": {
                    "address": {
                        "city": "Amiens", 
                        "country": "France", 
                        "zip": "80054"
                    }, 
                    "name": "Pr Marolleau"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "OUMEDALY RENAN, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Caen", 
                        "country": "France", 
                        "zip": "14000"
                    }, 
                    "name": "CHU CAEN"
                }, 
                "investigator": {
                    "last_name": "OUMEDALY RENAN, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59000"
                    }, 
                    "name": "Chru Lille"
                }, 
                "investigator": {
                    "last_name": "BRUNO QUESNEL, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "FABRICE JARDIN, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76000"
                    }, 
                    "name": "Chu Rouen"
                }, 
                "investigator": {
                    "last_name": "FABRICE JARDIN, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Incidence of Respiratory Viral Infections During AML Induction and Consolidation Chemotherapy", 
        "overall_contact": {
            "email": "marolleau.jean-pierre@chu-amiens.fr", 
            "last_name": "JEAN PIERRE MAROLLEAU, PU-PH", 
            "phone": "0322455914"
        }, 
        "overall_official": [
            {
                "affiliation": "CHU AMIENS", 
                "last_name": "Jean Pierre MAROLLEAU, MD PHD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "CHU ROUEN", 
                "last_name": "FABRICE JARDIN, MD PHD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "CHU CAEN", 
                "last_name": "OUMEDALY RENAN, MD PHD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "CHRU LILLE", 
                "last_name": "BRUNO QUESNEL, MD PHD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Positivity of the viral PCR in the presence of clinical signs during periods of Aplasia following chemotherapy induction and consolidation defining viral infection.", 
            "measure": "positivity of the viral PCR in the presence of clinical signs during periods of positivity of the PCR in the presence of clinical signs", 
            "safety_issue": "No", 
            "time_frame": "at day 15"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01819792"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "seasonal viral infection incidence measure", 
                "safety_issue": "No", 
                "time_frame": "18 months after inclusion"
            }, 
            {
                "measure": "risk factor of viral infections research", 
                "safety_issue": "No", 
                "time_frame": "18 months after inclusion"
            }, 
            {
                "measure": "viral infections related morbidity and mortality estimation", 
                "safety_issue": "Yes", 
                "time_frame": "18 months after inclusion"
            }, 
            {
                "measure": "bacterial and fungal co-infection estimation", 
                "safety_issue": "No", 
                "time_frame": "18 months after inclusion"
            }, 
            {
                "measure": "description of antiviral therapeutic used for treating patients", 
                "safety_issue": "No", 
                "time_frame": "18 months after inclusion"
            }
        ], 
        "source": "Centre Hospitalier Universitaire, Amiens", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire, Amiens", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}